WebJan 8, 2016 · Abstract. SUMOylation is a ubiquitin-related transient posttranslational modification pathway catalyzing the conjugation of small ubiquitin-like modifier (SUMO) proteins (SUMO1, SUMO2, and SUMO3) to lysine residues of proteins. SUMOylation targets a wide variety of cellular regulators and thereby affects a multitude of different cellular … WebMar 4, 2024 · Renal fibrosis is the common and final pathological process of kidney diseases. As a dynamic and reversible post-translational modification, SUMOylation and deSUMOylation of transcriptional factors and key mediators significantly affect the development of renal fibrosis. Recent advances suggest that SUMOylation functions as …
Desmopressin Injection: Uses, Side Effects, Interactions ... - WebMD
WebJun 24, 2024 · As shown in Supplementary Fig. 3a, b, treatment with the SUMOylation inhibitors ML-792 and 2-D08 slightly decreased the acetylation level, while treatment with the p300 inhibitor C646 ... WebSUMO E2 promotes SUMOs onto Lys residues of target substrate even in the absence of an SUMO E3. The small-molecule inhibitors targeting SUMOylation-associated enzymes can block the subsequent SUMO modification biochemical process. (A–C) Chemical structure of three inhibitors (ML-792, spectomycin B1, and triptolide). 886 Yang et al. binary search in python geeksforgeeks
DeSUMOylation of Apoptosis Inhibitor 5 by Avibirnavirus …
WebApr 1, 2024 · Here, we found that protease SENP1 directly interacts with and deSUMOylates JAK2, and the deSUMOylation of JAK2 leads to its accumulation at … WebMay 8, 2024 · Desmopressin is a drug that acts on the vasopressin receptors of the body. It has many relevant clinical uses, ranging from nocturnal enuresis to hemophilia. While this drug is relatively safe to use, … Cardiovascular diseases have recently become a leading contributor to the burden to the global health care systems and economy (1). Myocardial infarction (MI) jeopardizes the health and life of more than 7 million … See more MI occurs when blood supply to the heart is initially restricted. Upon the restoration of blood flow, the myocardial tissues receive concomitant reoxygenation. However, ischemia causes initial injury while reperfusion … See more The existing clinical therapies do not fully resolve MI/R injury in patients with coronary heart disease. The mechanism of SUMOylation has not yet been reported in clinical therapies … See more Proteostasis is essential for maintaining cellular function, especially for the myocardial cell with low mitotic activity. PTM is well-known to modulate protein function and fate, … See more binary search in new abap syntax